gratissimum demonstrated a multi-target inhibitory action against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidase B (MAO-B) targets that may be significant for the management and treatment of neurodegenerative illnesses .
← all excerpts
Network pharmacology based anti-diabetic attributes of bioactive compounds from <i>Ocimum gratissimum</i> L<i>.</i> through computational approach.
1
—
—